Archive · 20 Jul 2026
Tatva Chintan Pharma Shares Surge
Tatva Chintan Pharma Chemicals, a company that makes special chemicals, had a really good first quarter in 2026.
Their profits went up a lot, and so did their sales.
Because of this, their stock price went up by 20% to a new high.
A company called ICICI Securities thinks the stock could go even higher.
The company is also expecting to keep growing and making more money in the future.
However, some people think the stock might be too expensive now and could go down later.
Tatva Chintan Pharma Chemicals reported a 140% increase in net profit to Rs 16 crore in Q1 2026.
Revenue from operations rose 43% to Rs 167.1 crore in Q1 2026.
EBITDA increased 86% to Rs 32.3 crore in Q1 2026.
Shares surged 20% to a 52-week high of Rs 1714.
ICICI Securities set a price target of Rs 1955 for the stock.
- Who
- Tatva Chintan Pharma Chemicals
- What
- Stock price surge and strong Q1 earnings
- When
- Q1 2026
- Where
- India
- Why
- Strong financial performance and positive market sentiment
Investor Optimism
Market Caution
Stock Performance
Investor Optimism
Investors are optimistic about the company's strong financial performance and future growth prospects.
Market Caution
Some market analysts caution that the stock's rapid rise may be overvalued and could correct in the future.
- Net Profit
- Rs 16 crore (Q1 2026)
- Revenue from Operations
- Rs 167.1 crore (Q1 2026)
- EBITDA
- Rs 32.3 crore (Q1 2026)
- PAT Margin
- 10% (Q1 2026)
- Market Cap
- Rs 3971.27 crore
- Price Target
- Rs 1955 (ICICI Securities)